Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lindsay Androski currently holds 71,700 shares of Eloxx Pharmaceuticals, Inc. (ELOX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lindsay Androski has been a net neutral trader of ELOX stock. They have purchased $0 and sold $0 worth of shares.
Lindsay Androski's most recent insider trade was on Feb 2, 2026, when they sold 71,700 shares at $0.00 per share.
Lindsay Androski serves as Executive at Eloxx Pharmaceuticals, Inc. (ELOX). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Lindsay Androski holds the position of Executive at Eloxx Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Lindsay Androski has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Lindsay Androski was on Feb 2, 2026, when they purchased $0 worth of ABUS shares. This transaction involved 71,700 shares at N/A per share.
Lindsay Androski currently owns 71,700 shares of Eloxx Pharmaceuticals, Inc. (ELOX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lindsay Androski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lindsay Androski has 3 Form 4 filings on record as an insider at Eloxx Pharmaceuticals, Inc..
Set alerts for Lindsay Androski and 40,000+ other insiders.